Home
Yourgene Health

Yourgene Health Market Share Analysis for July 2026

The Sage™ Prenatal Screen is a non-invasive prenatal screening solution to estimate the risk of a fetus having Trisomy 21, Trisomy 18, Trisomy 13, Rare Autosomal Aneuploidies (RAA), Sex Chromosome Aneuploidies (SCA) and the most clinically relevant microdeletions.

Health > Biotechnology and Pharmaceuticals

Domainyourgene-health.com

Year Founded2013

Employees51 - 200

Annual Revenue$25M - $50M

Yourgene Health

Yourgene Health (including company regionals)

yourgene-health.com

See more website traffic and engagement information

Yourgene Health Revenue up to July 2026 is 25M - 50M

revenue generated by Yourgene Health top domains

Yourgene Health top domains revenue over 3 years

Revenue for Yourgene Health top domains

yourgene-health.com25M - 50M

See more with Sales Intelligence

Total visits to Yourgene Health's top domains

Understand Yourgene Health market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Yourgene Health's top domains

Analyze Yourgene Health engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Yourgene Health's top domains

See how Yourgene Health keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Yourgene Health top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Yourgene Health

These are the website technologies, by industry, used by Yourgene Health top domains

Advertising (8)

DoubleClick

Widget (5)

reCAPTCHA

Audio Video Media (3)

YouTube

Conversion & Analytics (3)

Google Analytics

More Technologies

8

See all

News & Signals from Yourgene Health

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsYourgene Health Plc receives financing of $7.72M.Yourgene Health has raised £6.4m in a share placing in order “to secure the future of the business”.

NewsYourgene Health Plc launched Sage 32 plex test on Jan 1st '19.In January 2019- Yourgene Health plc (U.K.) launched the Sage 32 plex test which uses Thermo Fisher’s Ion Torrent sequencing technology to detect placental cff-DNA in a maternal blood sample.

NewsYourgene Health Plc launched LightBench Detect on Jun 20th '22.Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, announces today the launch of the LightBench ® Detect, the latest addition to its Ranger ® Technology instrumentation portfolio at the 26 th International Conference on Prenatal Diagnosis and Therapy (ISPD).